Newsfiscal.ai
Lakewood-Amedex Biotherapeutics Completes Redemption of Series C Convertible Preferred Stock
· Published
Article summary
Lakewood-Amedex Biotherapeutics Inc. has finalized the redemption of all remaining outstanding shares of its Series C Convertible Preferred Stock.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…